Round 1 Winners!
Proof of Usefulness Report

AINovo Biotech

Analysis completed on 3/18/2026

+76
Proof of Usefulness Score
You're In Business

The submission makes highly dubious and exaggerated claims (e.g., 'most people have used my product', audience reach 'everyone') for a company with 30 employees and a $2.5M 'all time marketcap'. While AI-driven therapeutics is a strong problem domain, the profound lack of verifiable traction, vague technical details, and implausible responses result in a heavily penalized final score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+50
Audience Reach Impact+5
Technical Innovation+15
Evidence Of Traction+0
Market Timing Relevance+20
Functional Completeness+5
Subtotal+95
Usefulness Multiplierx0.8
Final Score+76

Project Details

Description
AINovo™ Biotech Inc. synthesizes and extracts insights from the world's largest and most diverse biological datasets to develop new therapeutics and diagnostics for human health. By combining massive datasets with our proprietary machine learning methods, rapid experimental iteration, and a highly interdisciplinary team, we are dramatically reducing the time and cost of bringing life-saving technologies to market.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline